There are three main categories of ovarian cancer: Epithelial. This is the most common type of ovarian cancer and includes about 90 percent of diagnosed cases. The tumor may resemble one of several ...

BRCA2-positive patients may have a 13 to 29 per cent risk of developing ovarian cancer and a higher than 60 per cent risk of breast cancer. The different types of ovarian cancers include epithelial ...

However, efforts are hampered by the rarity of non-high-grade serous carcinoma (HGSC) types, making trial recruitment in minor epithelial ovarian cancer (EOC) types challenging. Recent studies ...

Investigators at Dana-Farber Cancer Institute are opening a new clinical trial to evaluate a novel type of immune cellular ...

for the treatment of certain types of ovarian cancer. Elahere, an antibody-drug conjugate (ADC) that targets folate receptor alpha (FRα), has received full approval for the treatment of FRα-positive, ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer and full approval earlier this year, was the key asset in AbbVie's $10.1 billion ...

AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...

A breakthrough AI-powered liquid biopsy combining cell-free DNA and protein biomarkers improves early detection of ovarian ...